ST Nightingale: The application for the compound aerosol spray of one yellow flower branch meets the requirements for drug registration.

ST Bai Ling Announcement: Recently, we have received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration regarding the compound Huanghua Spray. The drug name is Compound Huanghua Spray, and the application content includes changing the applicable population and drug specifications. The approval conclusion is to approve the following supplementary application items: expand the main target population of this product to "children aged 6-13" for acute pharyngitis, change the drug specifications, and standardize the description of the specifications.